Background
==========

Cardiac NO-activated pathways are discussed to involve cross-talk between cGMP and cAMP signalling \[[@B1],[@B2]\]. Here we have investigated the signalling pathways relating to NO-donor S-nitroso-N-acetylpenicillamine (SNAP) modulation of L-type Ca^2+^ current (I~Ca,L~) in human right atrial cardiomyocytes.

Material and methods
====================

Experiments were performed on human biopsy tissue from 62 patients in sinus rhythm. I~Ca,L~ was measured with whole-cell voltage-clamp technique.

Results
=======

Application of SNAP (100µM) increased basal I~Ca,L~ from 5.93±0.23 pA/pF to 9.10±0.45pA/pF (p\<0.001, n/N=117/62). The effect was abolished by inhibition of soluble guanylate cyclase (sGC) with ODQ (30µM), suggesting involvement of cGMP. Stimulator of sGC (BAY 41-2272, 10nM--10µM) also increased I~Ca,L~ and this effect was potentiated in the presence of SNAP. Direct activation of protein kinase G (PKG) with 8-Br-cGMP (100 µM, intracellular application) increased basal I~Ca,L~. However, not only cGMP but also cAMP was involved, because, the effect of SNAP on I~Ca,L~ was prevented with the protein kinase A blocker (Rp-8-Br-cAMP 1 mM, intracellular). Thus, cGMP may activate I~Ca,L~ via direct activation of PKG and indirect activation of PKA at the same time. It is known, that cAMP-mediated activation of PKA is regulated by cGMP via modulation of phosphodiesterases (PDEs). The selective PDE2 inhibitor EHNA (10µM) did not affect basal or SNAP-stimulated I~Ca,L~, therefore PDE2 does not regulate basal cAMP level. In contrast, PDE3 inhibition with cilostamide (1µM) increased basal I~Ca,L~, suggesting that PDE3 is involved in basal cAMP level regulation. Interestingly, the cilostamide-induced increase in I~Ca,L~ is blunted upon addition of SNAP, most probably via activation of PDE2 by SNAP-mediated cGMP increase (Figure [1](#F1){ref-type="fig"}). Similarly, SNAP blunted enhancement of I~Ca,L~ by PKA activation with isoprenalin (1µM; 18.07 ± 1.12 pA/pF vs 23.06 ± 1.36 pA/pF, p\<0.001, n/N=21-39/18), however, this effect was prevented by PDE2 inhibition with EHNA.
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Conclusion
==========

We conclude that in human atrial cardiomyocytes NO-donors stimulate production of cGMP with further cross-talk to cAMP via PDE2 and PDE3.
